376 results on '"Hoag, Stephen W."'
Search Results
52. Effects of compaction and storage conditions on stability of intravenous immunoglobulin – Implication on developing oral tablets of biologics
53. Assessment of NIR spectroscopy for nondestructive analysis of physical and chemical attributes of sulfamethazine bolus dosage forms
54. Application of in-line near infrared spectroscopy and multivariate batch modeling for process monitoring in fluid bed granulation
55. Analysis of curing of a sustained release coating formulation by application of NIR spectroscopy to monitor changes physical–mechanical properties
56. Microenvironmental pH Modulation Based Release Enhancement of a Weakly Basic Drug from Hydrophilic Matrices
57. Assessment of Polymer-Polymer Interactions in Blends of HPMC and Film Forming Polymers by Modulated Temperature Differential Scanning Calorimetry
58. 848 DEVELOPMENT OF A NOVEL CHEMICAL DISSOLUTION FORMULATION AND ENDOSCOPIC DELIVERY DEVICE TO FACILITATE THE BREAKDOWN AND DRAINAGE OF PANCREATIC NECROSIS IN A SINGLE SESSION
59. Hedgehog pathway inhibitors significantly reduce the formation of heterotopic ossification in a direct trauma/burn mouse model
60. Assessment of the critical factors affecting the porosity of roller compacted ribbons and the feasibility of using NIR chemical imaging to evaluate the porosity distribution
61. 3D Nanoprinted Liquid-Core-Shell Microparticles
62. In Vitro Gastrointestinal Digestion of Palm Olein and Palm Stearin-in-Water Emulsions with Different Physical States and Fat Contents
63. Sustained release dosage forms dissolution behavior prediction: A study of matrix tablets using NIR spectroscopy
64. Theory of Force Transducer Design Optimization for Die Wall Stress Measurement During Tablet Compaction: Optimization and Validation of Split-Web Die Using Finite Element Analysis
65. Comparison of authentic and suspect pharmaceuticals
66. Evaluation of the deformation behavior of binary systems of methacrylic acid copolymers and hydroxypropyl methylcellulose using a compaction simulator
67. Erratum to: Use of Modeling and Simulation Tools for Understanding the Impact of Formulation on the Absorption of a Low Solubility Compound: Ciprofloxacin
68. Influence of methacrylic and acrylic acid polymers on the release performance of weakly basic drugs from sustained release hydrophilic matrices
69. L-Tetrahydropalmatine, a Novel Dopamine Antagonist, Fails to Improve Psychiatric Symptoms as Adjunctive Treatment for Schizophrenia
70. Understanding the impact of magnesium stearate variability on tableting performance using a multivariate modeling approach
71. Probing Thermal Stability of Proteins with Temperature Scanning Viscometer
72. Standardization of In Vitro Testing During Development of Abuse‐Deterrent Opioids: Highlights From the Second and Third Category 1 Focus Group Meetings
73. Open-label dose-extending placebos for opioid use disorder: a protocol for a randomised controlled clinical trial with methadone treatment
74. Characterization of the thermal properties of microcrystalline cellulose by modulated temperature differential scanning calorimetry
75. Solute diffusion in genetically engineered silk–elastinlike protein polymer hydrogels
76. Swelling behavior of a genetically engineered silk-elastinlike protein polymer hydrogel
77. Characterization of the interactions between polymethacrylate‐based aqueous polymeric dispersions and aluminum lakes
78. Design and Validation of an Annular Shear Cell for Pharmaceutical Powder Testing
79. The Impact of Formulation on Bioavailability: Summary of Workshop Discussion
80. A Multiparticulate Delivery System for Potential Colonic Targeting Using Bovine Serum Albumin as a Model Protein
81. Contributors
82. Early detection of capping risk in pharmaceutical compacts
83. Physical barrier type abuse-deterrent formulations: monitoring sintering-induced microstructural changes in polyethylene oxide placebo tablets by near infrared spectroscopy (NIRS)
84. Development and validation of a HPLC with fluorescence detection method to quantify the peanut allergen Ara h 2 in peanut extract and sublingual films
85. Developing a stable aqueous enteric coating formulation with hydroxypropyl methylcellulose acetate succinate (HPMCAS-MF) and colloidal silicon dioxide as anti-tacking agent
86. Impact of formulation excipients on the thermal, mechanical, and electrokinetic properties of hydroxypropyl methylcellulose acetate succinate (HPMCAS)
87. The impact of diluents on the compaction, dissolution, and physical stability of amorphous solid dispersion tablets.
88. Investigation of Polymer/Surfactant Interactions and Their Impact on Itraconazole Solubility and Precipitation Kinetics for Developing Spray-Dried Amorphous Solid Dispersions
89. Understanding the impact of magnesium stearate variability on tableting performance using a multivariate modeling approach.
90. Probing Thermal Stability of Proteins with Temperature Scanning Viscometer.
91. Understanding Pharmaceutical Quality by Design
92. A Systematic Approach of Employing Quality by Design Principles: Risk Assessment and Design of Experiments to Demonstrate Process Understanding and Identify the Critical Process Parameters for Coating of the Ethylcellulose Pseudolatex Dispersion Using Non-Conventional Fluid Bed Process
93. Formulation and Characterization of Orally Dissolving Thin Films containing the German cockroach Blatella germanica (Bla g 2) Allergen
94. <italic>In Vitro</italic> Assessment of Nasal Insufflation of Comminuted Drug Products Designed as Abuse Deterrent Using the Vertical Diffusion Cell.
95. Investigation of Polymer/Surfactant Interactions and Their Impact on Itraconazole Solubility and Precipitation Kinetics for Developing Spray-Dried Amorphous Solid Dispersions
96. Development and In Vivo Evaluation of a Novel Histatin-5 Bioadhesive Hydrogel Formulation against Oral Candidiasis
97. Application of Multivariate Strategies to the Classification of Pharmaceutical Excipient Manufacturers Based on Near-Infrared (NIR) Spectra
98. Restricted sedation and absence of cognitive impairments after administration of intranasal scopolamine
99. Intranasal scopolamine affects the semicircular canals centrally and peripherally
100. Quality-by-Design II: Application of Quantitative Risk Analysis to the Formulation of Ciprofloxacin Tablets
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.